The study claims that metformin treatment in low glucose environment enhances ovarian cancer cell cytotoxicity by apoptosis induction via mitochondrial pathway, which was confirmed by the increased ratio of Bax/Bcl-2. This evidence concerns the gene BCL2 and ovarian carcinoma.